Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Integra LifeSciences Holdings Corporation will announce its third quarter 2026 financial results on October 21, 2026, before market open, followed by a conference call hosted by management. The company operates as a global leader in medical technology, focusing on neurosurgery and tissue reconstruction.
Conexeu Sciences announced significant progress in scaling up manufacturing, conducting regulatory testing, and advancing preclinical studies to support the planned FDA 510(k) submission of its lead wound care device candidate, Ten Minute Tissue™, in the first quarter of 2027. The company has demonstrated reproducible manufacturing processes for it…
TowneBank announced a definitive merger agreement to acquire blueharbor bank for approximately $154 million. This deal will enhance TowneBank's presence in the greater Charlotte metropolitan area and the fast-growing I-77 corridor in North Carolina. blueharbor’s strong local lending relationships will combine with TowneBank’s broader resources, cre…
PowerCompute increased its contracted power at its Columbus, Mississippi data center from 8.5 MW to 11 MW under a new power contract with Columbus Light and Water, effective October 1, 2026. This move positions the site under TVA's Large Data Service rate with no assessed capacity commitment charge, which new customers would face at $1.5 million pe…
Runway Growth Finance Corp., a Nasdaq-listed specialty finance company, announced it will release its third quarter 2026 financial results on November 5, 2026, followed by a conference call to discuss results. The company provides flexible capital solutions to late- and growth-stage companies as an alternative to raising equity.
Orion Energy Systems, Inc., a NASDAQ-listed provider of energy-efficient LED lighting and EV charging solutions, is actively participating in numerous key industry events and summits including the FM Solutions Summit, APTA TRANSform & Expo, and NAESCO Annual Conference. These engagements highlight Orion's commitment to advancing lighting, IoT, and …
Arcutis Biotherapeutics announced that its topical eczema treatment, ZORYVE® (roflumilast) cream 0.15%, received the first-ever Marie Claire Beauty Award for Best Prescription Skin Solution. The award highlights ZORYVE’s innovative non-steroidal formulation designed for mild to moderate atopic dermatitis patients aged 6 and older. This recognition …
Wabtec (WAB) is showing continued earnings strength, a record backlog and contract wins that support upside. Fundamentals — $1.71B free cash flow, $49.3B market cap, and an improving technical setup — argue for a tactical long. Valuation is not cheap, so position sizing and a clear stop are essential.
ZenaTech, Inc. announced progress on the ZenaDrone 2000, a heavy-lift autonomous interceptor drone designed to counter hostile drones and swarm attacks over land and sea. The company is completing prototype assembly at its UAE facility and plans to begin flight testing in Q1 2027. The ZenaDrone 2000 aims to provide a cost-effective, long-endurance …
Turbo Energy announced the full operational deployment of 62.5 MWh of battery storage integrated with rooftop solar across three industrial sites in Spain, marking a significant milestone in its $53 million contract to deploy 366 MWh across 10 factories. The combined intelligent energy management system optimizes renewable energy use, reduces CO2 e…
Ocean Power Technologies (NYSE American: OPTT) completed a proof of concept by modifying its WAM-V 16 unmanned surface vessel to transport and deploy Greensea IQ's amphibious Bayonet 150 Autonomous Underwater Ground Vehicle offshore. The test demonstrated the vehicles' ability to work in tandem for maritime missions such as mine countermeasures, hi…
60 Degrees Pharmaceuticals announced it will conclude enrollment for its clinical trial of tafenoquine in severe babesiosis with 30 patients and plans to unblind and present primary and secondary endpoint results in January 2027. The company will also seek a pre-supplemental New Drug Application (pre-sNDA) meeting with the FDA to discuss regulatory…
Smart Sand (SND) looks positioned to benefit from rising proppant demand and favorable cash generation. At $5.36, shares trade at a modest multiple versus free cash flow and a sub-$250M market cap — attractive for a tactical swing that captures higher utilization and contract momentum. Entry, stop and targets below.
Micropolis Robotics, a UAE-based developer of autonomous robotics listed on NYSE American as MCRP, participated in Dubai's 'Proud of UAE' Cycling Race with its DPR2 Autonomous Patrols leading the event, demonstrating the deployment and operational readiness of its cutting-edge autonomous systems in real-world urban security and public safety applic…
Alpha Compute Corp., a US-based leader in sovereign super intelligence, has signed a binding $71.9 million contract to deploy its state-of-the-art ALPHA-02 NVIDIA B300 GPU compute cluster in a hydropowered data center in Sweden. This deal ensures long-term utilization of the high-density AI compute capacity ahead of full deployment, reflecting grow…
Ormat Technologies, Inc., a leading U.S.-based geothermal and renewable energy company, will release its Q3 2026 financial results on November 4, 2026, followed by a conference call. The company highlights its extensive global portfolio of geothermal, solar, and energy storage assets totaling 1,850MW, and its unique position as a vertically integra…
Global Ship Lease, a NYSE-listed containership owner and lessor, announced it has exercised options to build two additional state-of-the-art, mid-size, ultra-high-reefer, wide-beam containerships for approximately $163 million, with delivery scheduled in Q4 2029. This decision increases its newbuilding orderbook to 17 ships, aligning with its strat…
Collegium Pharmaceutical, a Nasdaq-listed biopharmaceutical firm, has launched Start Talking ADHD, an online resource with practical guides to assist patients and families managing ADHD in healthcare, education, and daily life contexts. The initiative accompanies Collegium's recent expansion of its ADHD medication portfolio, underscoring the compan…
Madrigal Pharmaceuticals announced publication of a secondary analysis from their Phase 3 MAESTRO-NASH trial demonstrating that Rezdiffra (resmetirom) effectively improves liver histology, reduces fibrosis, and lowers liver fat and biomarkers across multiple genetic variants associated with metabolic dysfunction-associated steatohepatitis (MASH). T…
Akebia Therapeutics announced multiple presentations at the ASN Kidney Week 2026, including a late-breaking presentation of the VOICE trial assessing vadadustat for anemia in hemodialysis patients, as well as posters on their rare kidney disease pipeline and clinical and economic outcomes for their drug Vafseo (vadadustat). These updates underscore…
LB Pharmaceuticals Inc (Nasdaq: LBRX) announced an in-person and virtual R&D Day on October 27, 2026, focusing on its lead investigational drug LB-102, a novel antipsychotic in Phase 3 development for schizophrenia. The event will feature presentations from key company executives and prominent psychiatrist Dr. Roger S. McIntyre, providing scientifi…
Entera Bio Ltd., a clinical-stage biopharmaceutical company developing oral peptide therapies, has appointed Laura Hamill, an experienced global commercial leader from Gilead Sciences and Amgen, to its Board of Directors effective December 1, 2026. This strategic move aims to leverage her expertise to support Entera’s late-stage clinical developmen…
Rezolve Ai, listed on NASDAQ as RZLV, hosted its Investor Day at the Nasdaq MarketSite showcasing its full agentic commerce platform with live demonstrations and revealing key findings from its US AI Visibility Study 2026. The study highlights a significant gap in AI agent engagement among America's largest retailers, underscoring the necessity for…
DeFi Development Corp. announced that its Board of Directors has authorized a repurchase program for its Variable Rate Series C Perpetual Preferred Stock (CHAD), allowing repurchase of up to all CHAD shares outstanding including future issuances. The program is designed to provide flexibility once CHAD reaches its $10 par value, enabling opportunis…
YD Bio Limited (Nasdaq: YDES) and EG BioMed have introduced an AI-based online cancer risk assessment tool that evaluates individual self-reported health data to generate personalized risk reports for ten major cancer types. This tool integrates with their oncology services and aims to empower users with insights for informed healthcare discussions…
